The head of the region held a meeting with the general director of the Italian company LEADER MEDICA SRL Roberto Minozzi on Thursday, April 13, 2017.
It is a leading company in the design, development and manufacture of medical products for implantology, orthopedics, traumatology and neurosurgery. The advantage of the company is in the complete management of the entire production cycle: from material processing to packaging of finished products, which ensures its high productivity and reliability.
The parties discussed the possibility of organizing a joint venture in Penza for the production of dental implants.
The governor told about the potential of the Penza region in the development of this sphere and the conditions for the work of investors.
"Dental implantation is a relatively new direction in dentistry, which has good prospects. In our region, innovative projects in the field of medicine are supported, we have a biomedical cluster, which includes 21 enterprises, "- Ivan Belozertsev said.
Roberto Minozzi expressed gratitude to the head of the region for the invitation to visit the Penza region and reported on the results of the company's work in recent years.
"The development of foreign markets is one of our priorities today," the director of LEADER MEDICA SRL shared.
Ivan Belozertsev instructed to organize interaction with the company's management on cooperation issues and demonstrate the potential of the Rameev Technopark, where it is proposed to organize a joint venture.
Also, the head of the region announced his readiness to assist in recruiting personnel for the new organization by attracting students and graduates of Penza universities.
Today, within the framework of the IV Inter-regional Forum "INNOMED" - 2017, it is planned to sign a protocol of intent on mutual cooperation between the government of the Penza region, "LEADER MEDICA SRL" and LLC "TITANMED".
The creation of a joint Russian-Italian production is of particular importance in terms of import substitution - currently more than 90% of dental implants in the country are produced abroad.